SABBY 13G SYN 1.17.19

Company

Theriva Biologics, Inc.

Filed

January 17, 2019

Accession Number

0001535610-19-000054

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →